MARTIN JAMES JOSEPH (Chief Financial Officer) received a stock award from COCRYSTAL PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/30/2025ACC: 0001493152-25-020218
Officer· Chief Financial Officer
Since Sep 2018
+10.79K
Net shares
Net buyer
$5.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
10.79K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.60K
Price / share
$1.39
Trade value
$5K
% of position
8.9%
10/28/2025
40.57K→44.17K
Total
Net shares
+3.60K
Net value
$5K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/28/2025 | A · Award | +3.60K | $1.39 | $5K | 8.9% | 40.57K | 44.17K |
| Total | +3.60K | $5K | ||||||
Derivative Transactions1
Warrants
Direct
Converts to
Common Stock
7.20K shares
Shares
+7.20K
Strike price
1.24
Held after
7.20K
Exercisable
—
10/28/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Direct | Common Stock7.20K shares | 10/28/2025 | A · Award | +7.20K | 1.24 | — | 7.20K |